SV119-gold nanocage conjugates: A new platform for targeting cancer cells via sigma-2 receptors

Yucai Wang; Jinbin Xu; Xiaohu Xia; Miaoxin Yang; Suwanna Vangveravong; Jingyi Chen; Robert H. MacH; Younan Xia

doi:10.1039/c1nr11469g

SV119-gold nanocage conjugates: A new platform for targeting cancer cells via sigma-2 receptors

Yucai Wang
, Jinbin Xu
, Xiaohu Xia
, Miaoxin Yang
, Suwanna Vangveravong
, Jingyi Chen
, Robert H. MacH
, Younan Xia

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.

Original language	English
Pages (from-to)	421-424
Number of pages	4
Journal	Nanoscale
Volume	4
Issue number	2
DOIs	https://doi.org/10.1039/c1nr11469g
State	Published - Jan 21 2012

Access to Document

10.1039/c1nr11469g

Cite this

@article{fe5330eae5154aafbd4e91829955ee2c,

title = "SV119-gold nanocage conjugates: A new platform for targeting cancer cells via sigma-2 receptors",

abstract = "We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.",

author = "Yucai Wang and Jinbin Xu and Xiaohu Xia and Miaoxin Yang and Suwanna Vangveravong and Jingyi Chen and MacH, \{Robert H.\} and Younan Xia",

year = "2012",

month = jan,

day = "21",

doi = "10.1039/c1nr11469g",

language = "English",

volume = "4",

pages = "421--424",

journal = "Nanoscale",

issn = "2040-3364",

number = "2",

}

TY - JOUR

T1 - SV119-gold nanocage conjugates

T2 - A new platform for targeting cancer cells via sigma-2 receptors

AU - Wang, Yucai

AU - Xu, Jinbin

AU - Xia, Xiaohu

AU - Yang, Miaoxin

AU - Vangveravong, Suwanna

AU - Chen, Jingyi

AU - MacH, Robert H.

AU - Xia, Younan

PY - 2012/1/21

Y1 - 2012/1/21

N2 - We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.

AB - We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.

UR - https://www.scopus.com/pages/publications/84855587763

U2 - 10.1039/c1nr11469g

DO - 10.1039/c1nr11469g

M3 - Article

C2 - 22113350

AN - SCOPUS:84855587763

SN - 2040-3364

VL - 4

SP - 421

EP - 424

JO - Nanoscale

JF - Nanoscale

IS - 2

ER -

SV119-gold nanocage conjugates: A new platform for targeting cancer cells via sigma-2 receptors

Abstract

Access to Document

Other files and links

Fingerprint

Cite this